| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Xiang Jun Wu CEO | XSHE Exchange | CNE1000015S0 ISIN |
| CN Country | 11,708 Employees | 16 Jun 2026 Last Dividend | 20 May 2015 Last Split | 28 Jul 2011 IPO Date |
Shijiazhuang Yiling Pharmaceutical Co., Ltd., established in 1992 and headquartered in Shijiazhuang, China, is a company centered on the development, production, and distribution of Chinese medicine. The company stands out in the pharmaceutical industry for its dedication to addressing a wide spectrum of health concerns through the lens of traditional Chinese medicinal practices, combined with modern research and development techniques. Shijiazhuang Yiling Pharmaceutical has made a significant mark primarily within the Chinese market, exemplifying growth and innovation in the field of alternative medicine.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. offers a diverse range of products and services tailored to meet various health needs. Each of their offerings is designed with a focus on leveraging traditional Chinese medicine principles alongside modern scientific research, ensuring quality and effectiveness. The company's offerings include: